Literature DB >> 6842184

Protection of newborn mice against herpes simplex virus infection by prenatal and postnatal transmission of antibody.

Y Hayashi, T Wada, R Mori.   

Abstract

Pre- and postnatally acquired protection against herpes simplex virus type 2(HSV-2) infection mediated by maternal antibody was investigated in the newborn mouse. Newborn mice, 2 days old, were inoculated with HSV-2 intraperitoneally after maternal immunization with live or inactivated virus. The survival rates improved in proportion to the maternal neutralizing antibody titres. Ninety-three percent of animals delivered by Caesarean section from immune mothers and suckled by non-immune mothers survived viral infection, whereas 7% of control animals survived. The same was true with animals born to non-immune mothers and nursed by immune mothers. In foetal sera and milk of immunized mice, anti-HSV activity was associated primarily with antibody of the IgG class as measured by enzyme-linked immunosorbent assay (ELISA). In addition, oral administration of antibody conferred protection on newborn mice. These studies indicate that maternal IgG, acquired not only postnatally but also prenatally, plays an important role in protecting newborn mice against HSV infection.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6842184     DOI: 10.1099/0022-1317-64-5-1007

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  9 in total

1.  Maternal immunization confers protection against neonatal herpes simplex mortality and behavioral morbidity.

Authors:  Chaya D Patel; Iara M Backes; Sean A Taylor; Yike Jiang; Arnaud Marchant; Jean M Pesola; Donald M Coen; David M Knipe; Margaret E Ackerman; David A Leib
Journal:  Sci Transl Med       Date:  2019-04-10       Impact factor: 17.956

2.  Preventing neonatal herpes infections through maternal immunization.

Authors:  Yike Jiang; David Leib
Journal:  Future Virol       Date:  2017-12       Impact factor: 1.831

3.  Maternal immunity partially protects newborn mice against a Chlamydia trachomatis intranasal challenge.

Authors:  Sukumar Pal; Olga Tatarenkova; Luis M de la Maza
Journal:  J Reprod Immunol       Date:  2010-06-15       Impact factor: 4.054

4.  Mechanisms of antibody-mediated protection against lymphocytic choriomeningitis virus infection: mother-to-baby transfer of humoral protection.

Authors:  J R Baldridge; M J Buchmeier
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

5.  Transplacental transfer and subsequent neonate utilization of herpes simplex virus-specific immunity are resilient to acute maternal stress.

Authors:  Jodi L Yorty; Robert H Bonneau
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

6.  Changes in immunoglobulin levels related to herpes simplex virus type 1 brain infection in pregnant mice.

Authors:  Javier S Burgos; Carlos Ramirez; Anna Brachet; Juan M Alfaro; Isabel Sastre; Fernando Valdivieso
Journal:  J Neurovirol       Date:  2007-06       Impact factor: 2.643

Review 7.  The immunologic basis for severe neonatal herpes disease and potential strategies for therapeutic intervention.

Authors:  Soren Gantt; William J Muller
Journal:  Clin Dev Immunol       Date:  2013-03-31

8.  Maternal Antiviral Immunoglobulin Accumulates in Neural Tissue of Neonates To Prevent HSV Neurological Disease.

Authors:  Yike Jiang; Chaya D Patel; Richard Manivanh; Brian North; Iara M Backes; David A Posner; Francesca Gilli; Andrew R Pachner; Lananh N Nguyen; David A Leib
Journal:  mBio       Date:  2017-07-05       Impact factor: 7.867

9.  Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine.

Authors:  Philip C LaTourette; Sita Awasthi; Angela Desmond; Norbert Pardi; Gary H Cohen; Drew Weissman; Harvey M Friedman
Journal:  Vaccine       Date:  2020-10-09       Impact factor: 3.641

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.